Labiotech.eu

In Depth 25 Feb 2020

Biotechnology Is Changing How We Make Clothes

The fashion industry is seeing the beginnings of a biotechnological revolution: using biology to make clothing to make textiles better and more sustainable. Biotechnology already plays an important role in the textile industry. Enzymes are used routinely to wash and bleach textiles, to give jeans a denim look or to prevent wool from shrinking. A […]

February 25, 2020 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Feb 2020

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to sign up as partners in the public-private genomics collaboration FinnGen. FinnGen’s pharma partners now total 11, including Sanofi and GSK, which joined early last year. Published 23/01/2019: Sanofi and GSK have joined up with a project collecting genomic and health […]

February 25, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Feb 2020

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

German biotech Adrenomed reports that its first-in-class antibody drug adrecizumab was well-tolerated by septic shock patients and met its primary goal in a phase II trial. The company says it will release more detailed trial data in a peer-reviewed paper later in the year, but states that patients given adrecizumab, as opposed to placebo, had […]

February 24, 2020 - 3 minutesmins - By Helen Albert

Best in Biotech 24 Feb 2020

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology has become a buzzword in biotech, with more and more companies starting up in Europe and elsewhere. With so many players involved, it can be hard to know who is doing what. Here are 20 European companies we think stand […]

February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin

Startup Scout 21 Feb 2020

This Startup is Developing Anti-Aging Antibodies

The Heidelberg-based startup Velabs Therapeutics aims to make anti-aging drugs that selectively destroy ‘aged’ cells in the body. Mission: To develop antibody drugs using microfluidics technology that can kill old or ‘senescent’ cells, which have been linked to the development of age-related conditions such as cardiovascular disease, dementia, and macular degeneration. While there are various […]

February 21, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Feb 2020

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

The German biotech Immatics will partner with GSK and could receive more than €1B from the big pharma for developing cancer immunotherapies based on engineered immune T-cells. Immatics will collaborate with GSK to develop two T-cell therapies that express a protein engineered to detect cancer antigens and kill cancer cells. In return, Immatics will receive […]

February 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Feb 2020

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment comes from Gamma Biosciences, an investment platform supported by the US investor KKR. Gamma Biosciences aims to acquire and invest in businesses developing gene and […]

February 19, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Feb 2020

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […]

February 18, 2020 - 2 minutesmins - By Helen Albert

News and Trends 17 Feb 2020

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted development of drugs targeting G protein-coupled receptors. OMass Therapeutics’s Series A initially raised €17M in late 2018. The new funds bring this up to €50M (£41.5M). Investors in the most recent fundraise included the UK VC firm Syncona — which […]

February 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2020

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and Italfarmaco to launch the biotech investment enterprise AurorA Science to support early stage biotechs. The partnership plans to invest €1–5M in each of one or two European start-ups this year. It is particularly focusing on promising biotechs in any area […]

February 14, 2020 - 2 minutesmins - By Laura Cowen

novadiscovery in silico clinical trial ai

Startup Scout 14 Feb 2020

Novadiscovery Carries out Clinical Trials using AI and Simulations

Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs. Mission: To predict the outcomes of clinical trials in silico using a combination of artificial intelligence (AI) and computational models of the biology underlying the disease. Clinical trials cost the healthcare industry billions of euros […]

February 14, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2020

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast technology, Innova Fit, which it says reduces biofuel production bottlenecks caused by conventional and basic yeast. Biofuels, including ethanol, are a renewable energy source being used as a replacement for fossil fuels, with substantially reduced CO2 emissions, particularly in the transport […]

February 14, 2020 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Biotechnology Is Changing How We Make Clothes

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

This Startup is Developing Anti-Aging Antibodies

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Novadiscovery Carries out Clinical Trials using AI and Simulations

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!